PROFOUND MED CORP's ticker is PROF and the CUSIP is 74319B502. A total of 32 filers reported holding PROFOUND MED CORP in Q3 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,617,211 | -25.7% | 550,707 | -5.3% | 0.01% | -23.1% |
| Q2 2023 | $7,561,880 | +58.8% | 581,236 | +13.4% | 0.01% | +44.4% |
| Q1 2023 | $4,763,011 | +37.6% | 512,703 | +61.3% | 0.01% | +28.6% |
| Q4 2022 | $3,460,951 | +2222.8% | 317,810 | +759.5% | 0.01% | – |
| Q3 2022 | $149,000 | -45.2% | 36,978 | -0.7% | 0.00% | -100.0% |
| Q2 2022 | $272,000 | -35.5% | 37,245 | -20.6% | 0.00% | 0.0% |
| Q1 2022 | $422,000 | -3.2% | 46,911 | +21.4% | 0.00% | 0.0% |
| Q4 2021 | $436,000 | -58.6% | 38,629 | -46.5% | 0.00% | -50.0% |
| Q3 2021 | $1,053,000 | +7.4% | 72,215 | +20.0% | 0.00% | 0.0% |
| Q2 2021 | $980,000 | -19.1% | 60,162 | -0.3% | 0.00% | -33.3% |
| Q1 2021 | $1,211,000 | +3.4% | 60,356 | +6.0% | 0.00% | 0.0% |
| Q4 2020 | $1,171,000 | +55.9% | 56,956 | +33.4% | 0.00% | +50.0% |
| Q3 2020 | $751,000 | +291.1% | 42,698 | +276.8% | 0.00% | +100.0% |
| Q2 2020 | $192,000 | +29.7% | 11,333 | -26.2% | 0.00% | 0.0% |
| Q1 2020 | $148,000 | – | 15,356 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 341,767 | $7,029,000 | 13.80% |
| GAGNON SECURITIES LLC | 821,196 | $16,883,000 | 2.69% |
| Gagnon Advisors, LLC | 277,252 | $5,700,000 | 2.56% |
| Taylor Wealth Management Partners | 166,294 | $3,419,000 | 1.32% |
| PCJ Investment Counsel Ltd. | 126,930 | $2,611,000 | 1.22% |
| EAM Global Investors LLC | 172,291 | $3,542,000 | 0.96% |
| AWM Investment Company, Inc. | 348,939 | $7,174,000 | 0.91% |
| PURA VIDA INVESTMENTS, LLC | 780,567 | $16,048,000 | 0.58% |
| Wealth Management Partners, LLC | 20,282 | $554,000 | 0.43% |
| Parkman Healthcare Partners LLC | 69,049 | $1,420,000 | 0.36% |